Race/ethnicity and the prevalence of thyrotoxicosis in young Americans

Thyroid

Volumn 25, Issue 6, 2015, Pages 621-628

  McLeod, Donald S A ^a,b   Cooper, David S ^c   Ladenson, Paul W ^c   Whiteman, David C ^b   Jordan, Susan J ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE; ANTITHYROID AGENT;

ADOLESCENT; ADULT; AMERICAN; ARTICLE; BLACK PERSON; CAUCASIAN; CHILD; ETHNICITY; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICAN AMERICAN; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; THYROID GLAND; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; AFRICAN AMERICAN; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; NUTRITION; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANTITHYROID AGENTS; CHILD; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHIMAZOLE; MEXICAN AMERICANS; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; PROPYLTHIOURACIL; RISK FACTORS; THYROTOXICOSIS; THYROTROPIN; UNITED STATES; YOUNG ADULT;

EID: 84930516703     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0504     Document Type: Article

References (39)

1. Davies TF 2013 Pathogenesis of Graves' disease. In: Braverman LE, Cooper DS, (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Tenth ed. Lippincott Williams & Wilkins, Philadelphia, PA, pp 356-369.
2. Brownlie BE, Wells JE 1990 The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985. Clin Endocrinol (Oxf) 33:249-259.
3. Abraham-Nordling M, Byström K, Törring O, Lantz M, Berg G, Calissendorff J, Nyström HF, Jansson S, Jörneskog G, Karlsson FA, Nyström E, Ohrling H, Ö rn T, Hallengren B, Wallin G 2011 Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 165:899-905.
4. Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Laurberg P 2011 Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 164:801-809.
5. McLeod DS, Caturegli P, Cooper DS, Matos PG, Hutfless S 2014 Variation in rates of autoimmune thyroid disease by race/ethnicity in United States military personnel. JAMA 311:1563-1565.
6. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). About the National Health and Nutrition Examination Survey. Available at www.cdc.gov/nchs/nhanes/about-nhanes.htm (accessed October 14, 2014).
7. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). NHANES III. Available at www.cdc.gov/nchs/nhanes/nh3data.htm (accessed October 14, 2014).
8. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). NHANES 1999-2000. Available at wwwn.cdc.gov/nchs/nhanes/search/nhanes99-00.aspx (accessed October 14, 2014).
9. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). NHANES 2001-2002. Available at wwwn.cdc.gov/nchs/nhanes/search/nhanes01-02.aspx (accessed October 14, 2014).
10. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). NHANES 2007-2008. Available at wwwn.cdc.gov/nchs/nhanes/search/nhanes07-08.aspx (accessed October 14, 2014).
11. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). NHANES 2009-2010. Available at wwwn.cdc.gov/nchs/nhanes/search/nhanes09-10.aspx (accessed October 14, 2014).
12. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). Sample design: third National Health and Nutrition Examination Survey. Available at www.cdc.gov/nchs/data/series/sr-01/sr01-032.pdf (accessed October 14, 2014).
13. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). Analytic Note Regarding 2007-2010 Survey Design Changes and Combining Data Across other Survey Cycles. Available at www.cdc.gov/nchs/data/nhanes/analyticnote-2007-2010.pdf (accessed October 14, 2014).
14. Centers for Disease Control and Prevention (CDC). National Center forHealth Statistics (NCHS). Response rates and population totals. Available at www.cdc.gov/nchs/nhanes/response-rates-CPS.htm (accessed October 14, 2014).
15. Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR 2013 National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital Health Statistics 2 161:1-24.
16. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
17. Lohr SL 2010 Sampling: Design and Analysis. Second ed. Brooks/Cole, Boston.
18. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). Analytic and reporting guidelines: The Third National Health and Nutrition Examination Survey, NHANES III (1988-94). Available www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf (accessed October 14, 2014).
19. Boucai L, Surks MI 2009 Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf) 70:788-793.
20. Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L, Berrino F, van den Brandt PA, Buring JE, Cho E, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Harnack L, Horn-Ross PL, Krogh V, Leitzmann MF, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Schatzkin A, Shore R, Virtanen M, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Hunter DJ 2006 Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 163:1053-1064.
21. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR 2007 Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 17:1211-1223.
22. Kalk WJ 1981 Thyrotoxicosis in urban black Africans: a rising incidence. East Afr Med J 58:109-116.
23. Burek CL, Hoffman WH, Rose NR 1982 The presence of thyroid autoantibodies in children and adolescents with autoimmune thyroid disease and in their siblings and parents. Clin Immunol Immunopathol 25:395-404.
24. Burek CL, Rose NR, Guire KE, Hoffman WH 1990 Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 7:157-167.
25. Hutfless S, Matos P, Talor MV, Caturegli P, Rose NR 2011 Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. J Clin Endocrinol Metab 96:E1466-1471.
26. Brix TH, Kyvik KO, Christensen K, Hegedus L 2001 Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86:930-934.
27. McLachlan SM, Rapoport B 2014 Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev 35:59-105.
28. Tomer Y 2014 Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Ann Rev Pathol 9: 147-156.
29. Sridama V, Hara Y, Fauchet R, DeGroot LJ 1987 HLA immunogenetic heterogeneity in black American patients with Graves' disease. Arch Intern Med 147:229-231.
30. Omar MA, Hammond MG, Desai RK, Motala AA, Aboo N, Seedat MA 1990 HLA class I and II antigens in South African blacks with Graves' disease. Clin Immunol Immunopathol 54:98-102.
31. Ofosu MH, Dunston G, Henry L, Ware D, Cheatham W, Brembridge A, Brown C, Alarif L 1996 HLA-DQ3 is associated with Graves' disease in African-Americans. Immunol Invest 25:103-110.
32. Yanagawa T, DeGroot LJ 1996 HLA class II associations in African-American female patients with Graves' disease. Thyroid 6:37-39.
33. Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK 2000 The human leukocyte antigen HLA DRB3∗020/DQA1∗0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab 85:1545-1549.
34. Smikle MF, Pascoe RW, Barton E, Morgan O, Christian N, Dowe G, Roye-Green K, Bailey V, James O 2001 HLADRB3∗0101 is associated with Graves' disease in Jamaicans. Clin Endocrinol (Oxf) 55:805-808.
35. Hatch SL, Dohrenwend BP 2007 Distribution of traumatic and other stressful life events by race/ethnicity, gender, SES and age: a review of the research. Am J Community Psychol 40:313-332.
36. Winsa B, Adami HO, Bergström R, Gamstedt A, Dahlberg PA, Adamson U, Jansson R, Karlsson A 1991 Stressful life events and Graves' disease. Lancet 338:1475-1479.
37. Bagnasco M, Bossert I, Pesce G 2006 Stress and autoimmune thyroid diseases. Neuroimmunomodulation 13:309-317.
38. Roberts AL, Gilman SE, Breslau J, Breslau N, Koenen KC 2011 Race/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States. Psychol Med 41:71-83.
39. Alegria M, Fortuna LR, Lin JY, Norris FH, Gao S, Takeuchi DT, Jackson JS, Shrout PE, Valentine A 2013 Prevalence, risk, and correlates of posttraumatic stress disorder across ethnic and racial minority groups in the United States. Med Care 51:1114-1123.